4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-22-006742
Options or other derivatives
- Director acquired 13,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bonstein Sara Director | 2022-06-15 | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | D | ||
Loading xslF345X03/form4-06172022_040601.xml…